ErVaccine raises €4.5M to start therapeutic cancer vaccine trial
ErVaccine Technologies, announces the closing of a €4.5 million ($4.8 million) seed round, including dilutive…
January 9, 2023 - 3 minutes
ErVaccine Technologies, announces the closing of a €4.5 million ($4.8 million) seed round, including dilutive…